Two Sigma Investments’s ChemoCentryx, Inc. CCXI Stock Holding History

Two Sigma Investments’s Portfolio CCXI Stock Details CCXI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q3	–	Sell	-11,500	Closed	-$285K	–	2984
2022 Q2	$285K	Sell	11,500 -770,494	-99%	-$17M	﹤0.01%	2045
2022 Q1	$19.6M	Sell	781,994 -54,541	-7%	-$1.53M	0.06%	392
2021 Q4	$30.5M	Buy	836,535 +753,735	+910%	+$26.5M	0.07%	342
2021 Q3	$1.42M	Sell	82,800 -179,800	-68%	-$2.8M	﹤0.01%	2294
2021 Q2	$3.52M	Buy	+262,600	New	+$6.47M	0.01%	1432
2020 Q4	–	Sell	-104,965	Closed	-$5.75M	–	3897
2020 Q3	$5.75M	Sell	104,965 -191,766	-65%	-$10.3M	0.02%	740
2020 Q2	$17.1M	Buy	296,731 +253,021	+579%	+$13.8M	0.08%	251
2020 Q1	$1.76M	Sell	43,710 -6,776	-13%	-$288K	0.01%	1035
2019 Q4	$2M	Sell	50,486 -63,191	-56%	-$1.11M	0.01%	1589
2019 Q3	$771K	Sell	113,677 -56,963	-33%	-$428K	﹤0.01%	2205
2019 Q2	$1.59M	Sell	170,640 -61,616	-27%	-$713K	0.01%	1599
2019 Q1	$3.23M	Buy	232,256 +179,894	+344%	+$2.06M	0.01%	1183
2018 Q4	$571K	Sell	52,362 -88,419	-63%	-$932K	﹤0.01%	2015
2018 Q3	$1.78M	Sell	140,781 -116,992	-45%	-$1.41M	﹤0.01%	1564
2018 Q2	$3.4M	Buy	257,773 +142,700	+124%	+$1.71M	0.01%	1261
2018 Q1	$1.56M	Buy	+115,073	New	+$1.19M	0.01%	1701
2016 Q2	–	Sell	-63,617	Closed	-$158K	–	3337
2016 Q1	$158K	Buy	63,617 +31,080	+96%	+$113K	﹤0.01%	2629
2015 Q4	$264K	Buy	+32,537	New	+$230K	﹤0.01%	2317
2015 Q1	–	Sell	-32,220	Closed	-$220K	–	2936
2014 Q4	$220K	Buy	+32,220	New	+$170K	﹤0.01%	2023
2014 Q1	–	Sell	-76,657	Closed	-$445K	–	2340
2013 Q4	$445K	Buy	+76,657	New	+$395K	﹤0.01%	1710

Other funds holding CCXI

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

UOC

UBS O'Connor Chicago, Illinois $3.38B AUM 63.08% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

PCM

Pentwater Capital Management Naples, Florida $19.3B AUM 58.13% 1-Year Est. Return

BBA

Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return

SFM

Soros Fund Management New York $9.12B AUM 30.69% 1-Year Est. Return

Healthcare of Ontario Pension Plan (HOOPP) Trust Fund Toronto, Ontario, Canada $62.2B AUM 31.35% 1-Year Est. Return

Two Sigma Investments's CCXI Position: Q3 2022 in Review

Two Sigma Investments sold out of ChemoCentryx, Inc. (CCXI) in Q3 2022, closing a stake of 11,500 shares — an estimated $285K sold.

Two Sigma Investments first reported a position in CCXI in Q4 2013 and held it in 20 quarters. The position peaked at $30.5M in Q4 2021. 217 funds tracked by Wall St. Rank hold CCXI as of Q3 2022.

Two Sigma Investments reported no remaining ChemoCentryx, Inc. position as of Q3 2022 after selling out during the quarter.
Two Sigma Investments sold 11,500 ChemoCentryx, Inc. shares in Q3 2022, an estimated $285K.
Two Sigma Investments first reported a position in ChemoCentryx, Inc. in Q4 2013 and held it in 20 quarters.
Two Sigma Investments's ChemoCentryx, Inc. position peaked at $30.5M in Q4 2021.
217 funds tracked by Wall St. Rank held ChemoCentryx, Inc. as of Q3 2022.

Based on Two Sigma Investments's 13F filing for Q3 2022, filed 14 Nov 2022.